Allarity Therapeutics, Inc. Interest Expense Nonoperating
Allarity Therapeutics, Inc. (ALLR) reported Interest Expense Nonoperating of $719.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- Allarity Therapeutics, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $719.00K, a 5891.67% increase year-over-year.
- Allarity Therapeutics, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $229.00K, a 301.75% increase year-over-year.
- Allarity Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $59.00K, a 21.33% decline year-over-year.
- Allarity Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $57.00K, a 14.00% increase year-over-year.
- Allarity Therapeutics, Inc. interest expense nonoperating for fiscal 2025 was $185.00K, a 71.67% decline from fiscal 2024.
- Allarity Therapeutics, Inc. interest expense nonoperating for fiscal 2024 was $653.00K, a 31.12% increase from fiscal 2023.
- Allarity Therapeutics, Inc. interest expense nonoperating for fiscal 2023 was $498.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $719.00K 10-Q · filed 2026-08-14 | $948.00K 10-Q · filed 2026-08-14 | $1.01M derived: sum of 3 quarters · filed 2026-08-14 | $1.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $229.00K 10-Q · filed 2026-05-15 | $288.00K derived: sum of 2 quarters · filed 2026-05-15 | $345.00K derived: sum of 3 quarters · filed 2026-05-15 | $357.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $116.00K derived: sum of 2 quarters · filed 2026-03-30 | $128.00K derived: sum of 3 quarters · filed 2026-08-14 | $185.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $57.00K 10-Q · filed 2025-11-14 | $69.00K derived: sum of 2 quarters · filed 2026-08-14 | $126.00K 10-Q · filed 2025-11-14 | $201.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $12.00K 10-Q · filed 2026-08-14 | $69.00K 10-Q · filed 2026-08-14 | $144.00K derived: sum of 3 quarters · filed 2026-08-14 | $194.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $57.00K 10-Q · filed 2026-05-15 | $132.00K derived: sum of 2 quarters · filed 2026-05-15 | $182.00K derived: sum of 3 quarters · filed 2026-05-15 | $608.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $125.00K derived: sum of 2 quarters · filed 2026-03-30 | $551.00K derived: sum of 3 quarters · filed 2026-03-30 | $653.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-14 | $476.00K derived: sum of 2 quarters · filed 2025-11-14 | $578.00K 10-Q · filed 2025-11-14 | $808.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $426.00K 10-Q · filed 2025-08-15 | $528.00K 10-Q · filed 2025-08-15 | $758.00K derived: sum of 3 quarters · filed 2025-08-15 | $792.00K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | $102.00K 10-Q · filed 2025-05-09 | $332.00K derived: sum of 2 quarters · filed 2025-05-09 | $366.00K derived: sum of 3 quarters · filed 2025-05-09 | $508.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $264.00K derived: sum of 2 quarters · filed 2025-03-31 | $406.00K derived: sum of 3 quarters · filed 2025-03-31 | $498.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $34.00K 10-Q · filed 2024-11-14 | $176.00K derived: sum of 2 quarters · filed 2024-11-14 | $268.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $142.00K 10-Q · filed 2024-08-05 | $234.00K 10-Q · filed 2024-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |